NAD+ IV Therapy

NAD+ (nicotinamide adenine dinucleotide) intravenous infusions to replenish the coenzyme essential for cellular energy production, DNA repair, and sirtuin activation — core mechanisms of healthy ageing. Administered under physician supervision at Asia Longevity.

NAD+ is one of the most abundant and essential molecules in the human body, yet its levels decline by roughly 50 % between the ages of 40 and 60. This decline is closely linked to reduced cellular energy, impaired DNA repair, mitochondrial dysfunction, cognitive decline, and many hallmarks of accelerated ageing. Replenishing NAD+ via intravenous infusion is among the most direct and effective strategies available in longevity medicine today. At Asia Longevity, NAD+ infusions are delivered slowly over 90 to 120 minutes to maximise comfort and absorption, administered under the direct supervision of a qualified physician. Dosing is individualised based on the patient's baseline NAD+ levels (measured via blood test), health history, and therapeutic goals. Typical protocols range from 250 mg to 1,000 mg per session, with an initial loading series of three to five infusions over two weeks, followed by monthly maintenance. Clinical benefits reported by patients and supported by emerging research include dramatically improved energy and stamina, sharper mental focus and reduced brain fog, faster muscle recovery after exercise, improved mood and emotional resilience, and deeper, more restorative sleep. NAD+ also activates sirtuins — a class of longevity proteins that regulate inflammation, metabolism, and cellular stress response — making it a cornerstone of comprehensive anti-ageing medicine. The clinic pairs NAD+ therapy with before-and-after biomarker testing so that objective improvements in metabolic and inflammatory markers can be tracked. For patients on the Signature or Pinnacle longevity assessment packages, NAD+ infusions are often integrated into a broader protocol alongside hormone optimisation and micronutrient support.